Valuation: Haleon Pakistan Limited

Capitalization 87.76B 311M 268M 253M 229M 423M 26.6B 476M 2.94B 1.15B 12.22B 1.17B 1.14B 44.65B P/E ratio 2023
19.9x
P/E ratio 2024 20.7x
Enterprise value 81.26B 288M 249M 234M 212M 392M 24.63B 441M 2.72B 1.06B 11.32B 1.08B 1.06B 41.34B EV / Sales 2023
0.5x
EV / Sales 2024 2.37x
Free-Float
14.2%
Yield 2023 *
-
Yield 2024 2.48%
More valuation ratios * Estimated data
Dynamic Chart
1 day+0.04%
1 week+1.97%
Current month+2.70%
1 month+0.30%
3 months-8.98%
6 months-17.68%
Current year-7.17%
More quotes
1 week 710.03
Extreme 710.03
759
1 month 700
Extreme 700
760
Current year 653.14
Extreme 653.14
914
1 year 270
Extreme 270
975
3 years 120
Extreme 120
975
5 years 120
Extreme 120
975
10 years 65.05
Extreme 65.0548
975
More quotes
Manager TitleAgeSince
Director of Finance/CFO - 2020-10-26
Compliance Officer - 2023-02-19
Investor Relations Contact - 2020-05-30
Director TitleAgeSince
Director/Board Member - 2016-06-22
Director/Board Member - 2020-08-25
Director/Board Member - 2020-10-26
More insiders
Change 5d. change 1-year change 3-years change Capi.($)
+0.04%+1.97%+176.16%+218.37% 311M
+0.02%+0.51%+11.72%+103.47% 47.28B
-1.89%+6.98%+13.88%+62.69% 27.15B
-0.98%-2.93%+32.78% - 22.86B
+0.16%+0.07%-2.55%+57.65% 14.17B
-0.39%+1.54%-10.60%+177.17% 11.5B
+4.47%+16.34%+94.51%+108.26% 8.42B
-.--%+0.14% - - 6.79B
+0.27%+1.35%+37.73%+99.15% 6.65B
-.--%-1.95% - - 5.73B
Average +0.17%+2.71%+44.21%+118.11% 15.09B
Weighted average by Cap. -0.23%+2.28%+18.97%+96.01%
See all sector performances

Financials

2023 2024
Net sales 31.61B 112M 96.67M 91.01M 82.35M 152M 9.58B 172M 1.06B 413M 4.4B 420M 411M 16.08B 37.21B 132M 114M 107M 96.93M 179M 11.28B 202M 1.24B 486M 5.18B 494M 484M 18.93B
Net income 996M 3.52M 3.04M 2.87M 2.59M 4.8M 302M 5.4M 33.3M 13M 139M 13.22M 12.94M 506M 4.58B 16.2M 14M 13.18M 11.93M 22.07M 1.39B 24.85M 153M 59.79M 638M 60.79M 59.51M 2.33B
Net Debt -4.05B -14.33M -12.38M -11.66M -10.55M -19.52M -1.23B -21.98M -135M -52.89M -564M -53.77M -52.64M -2.06B -6.5B -23M -19.87M -18.71M -16.93M -31.32M -1.97B -35.28M -217M -84.88M -905M -86.3M -84.48M -3.31B
More financial data * Estimated data
Logo Haleon Pakistan Limited
Haleon Pakistan Limited, formerly Glaxosmithkline Consumer Healthcare Pakistan Limited, is a Pakistan-based healthcare company. The Company's product portfolio consists of five categories, namely oral health, pain relief, respiratory health, digestive health, and other and vitamins, minerals and supplements (VMS). Its geographical segment consists of North America; Europe, Middle East and Africa (EMEA), and Latin America (LatAm), and Asia-Pacific (APAC). The Brands under Oral Health include Sensodyne, Parodontax, Polident, and Biotene. Its Vitamins, Minerals and Supplements offers a portfolio of brands, such as Centrum, a multivitamin and mineral brand; calcium supplements through its Caltrate brand, and vitamin C supplements through Emergen-C. The Brands under Respiratory consists of Otrivin, Theraflu, and Flonase. The Company's Pain Relief product includes Panadol, Voltaren, and Advil brands. Its portfolio digestive health brands consist of Eno, Tums, and Fenistil.
Employees
450
More about the company
Date Price Change Volume
25-06-12 749.76 +0.04% 53,271
25-06-11 749.45 +2.30% 75,005
25-06-10 732.60 -0.36% 173,209
25-06-05 735.24 +1.60% 48,184
25-06-04 723.65 +2.83% 84,596

End-of-day quote Pakistan S.E., June 11, 2025

More quotes
  1. Stock Market
  2. Equities
  3. HALEON Stock